Daiwa Securities Group Inc. Acadia Pharmaceuticals Inc Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 641 shares of ACAD stock, worth $11,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares

641

Previous 551 16.33%

Holding current value

$11,063

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $1,362 - $1,722	90 Added 16.33%	641 $10,000
Q2 2024 Aug 07, 2024	SELL	$14.62 - $18.42 $1,462 - $1,842	-100 Reduced 15.36%	551 $9,000
Q4 2022 Feb 06, 2023	BUY	$14.2 - $18.63 $2,584 - $3,390	182 Added 38.81%	651 $10,000
Q4 2021 Feb 03, 2022	SELL	$16.79 - $27.09 $1,359 - $2,194	-81 Reduced 14.73%	469 $11,000
Q3 2021 Nov 05, 2021	BUY	$15.78 - $24.77 $3,676 - $5,771	233 Added 73.5%	550 $9,000
Q1 2021 May 03, 2021	BUY	$25.02 - $54.99 $450 - $989	18 Added 6.02%	317 $8,000
Q4 2020 Feb 04, 2021	SELL	$41.04 - $56.79 $24,213 - $33,506	-590 Reduced 66.37%	299 $16,000
Q3 2020 Nov 02, 2020	BUY	$36.42 - $57.0 $728 - $1,140	20 Added 2.3%	889 $37,000
Q4 2019 Jan 31, 2020	SELL	$36.21 - $51.4 $1,665 - $2,364	-46 Reduced 5.03%	869 $37,000
Q1 2019 Apr 26, 2019	SELL	$16.17 - $27.38 $610,789 - $1.03 Million	-37,773 Reduced 97.63%	915 $25,000
Q4 2018 Feb 05, 2019	SELL	$14.32 - $22.92 $46,010 - $73,641	-3,213 Reduced 7.67%	38,688 $625,000
Q3 2018 Nov 01, 2018	SELL	$13.03 - $21.81 $196,818 - $329,440	-15,105 Reduced 26.5%	41,901 $870,000
Q2 2018 Jul 30, 2018	SELL	$15.07 - $22.34 $245,475 - $363,896	-16,289 Reduced 22.22%	57,006 $870,000
Q1 2018 May 02, 2018	BUY	$22.47 - $32.33 $32,514 - $46,781	1,447 Added 2.01%	73,295 $1.65 Million
Q4 2017 Feb 06, 2018	BUY	$26.84 - $39.14 $1.93 Million - $2.81 Million	71,848	71,848 $2.16 Million

Others Institutions Holding ACAD

# of Institutions

281

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Acadia Pharmaceuticals Inc Transaction History